CAI

Caris Life Sciences, Inc.
36.14 +1.95% 2026-10-29

Last 90d 3 insider sales

52-week range
14.19 36.50
1-month+18.0%
3-month+130.6%
1-year+19.0%
vs 50-day+24.8%
vs 200-day+67.8%
Volatility68%
Beta1.41
$ vol/day$110M
ATH42.50
From ATH-15.0%
Next report2026-11-04
Nothing written about CAI yet. Be the first — call it long or short with an entry we price for you, or post a neutral write-up that takes no side. Create a free account
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

WhenPeople SizeValuePrice
1mo sell 1 $238,626 32.00
1mo sell 1 $12,132,080 29.95
2mo sell 1 $14,834,107 24.80
4mo buy 1 $990,080 16.85
6mo buy 1 $501,457 16.64
11mo sched 1 $1,654,200 26.46
12mo buy 2 $110,333 25.20
1.4y buy 2 $787,500 26.37

Next report 2026-11-04 (Wednesday, after close, in 5 days) · EPS estimate 0.02. It has finished the next session higher 60% of the time, average move 13.2%.

Day-after move, last 5 reports, oldest left.

ReportedEst.Actual SurpriseGapDay 1Day 5
2026-08-05 miss 0.01 — -100.0% +15.5% +21.6% +34.8%
2026-05-07 beat -0.02 — +100.0% -15.3% -18.6% -26.7%
2026-02-26 beat 0.10 0.28 +168.7% +10.0% +4.7% -3.4%
2025-11-05 beat -0.14 0.08 +158.8% +2.7% -15.7% -16.8%
2025-08-12 miss -0.22 -1.11 -411.2% +22.6% +5.6% +8.0%
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.4%
Next 1 week
+2.4%
Next 1 month
+4.0%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply overbought — RSI(2) at 99
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Mean-reversion stats →
1-month breakdown — Market · β 1.41 +4.0%
$110M/day volume 68% volatility +19% 1-year -15% from ATH
52-week range · 98% of the way up · -1% from the high
$14.19$36.50

Not investment advice.